Skip to main content
BDMD logo
BDMD
(NASDAQ)
Baird Medical Investment Holdings Limited
$1.02-- (--)
Loading... - Market loading

Baird Medical Investment Holdings (BDMD) Key Statistics & Financial Metrics

Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.

Stock Valuation Metrics

Market value, earnings multiples, and pricing ratios

Market Valuation & Earnings Multiples

Market capitalization, P/E ratios, and enterprise value

Market Cap28.35M
Enterprise Value47.33M

Price-Based Ratios

Valuation ratios based on stock price

Price/Sales (ttm)0.48
Price/Book (mrq)0.90
Price/Tangible Book (mrq)0.91

Enterprise Value Ratios

EV-based valuation multiples

EV/Revenue0.79
EV/Earnings-3.19
EV/EBITDA-6.10
EV/EBIT-1.85
EV/FCF-4.48

Stock Price

Current price, 52-week range, and moving averages

Current Price$1.02
1-Day Change-2.86%
52-Week High$3.75
52-Week Low$0.76
52-Week Change-56.22%
YTD Change-23.88%
1-Year Change-52.56%
50-Day MA$1.28
200-Day MA$1.51
Avg Volume (30 day)100.76K

Share Statistics

Outstanding shares, float, and per-share metrics

Shares Outstanding27.79M
Book Value per Share$1.13
Net Cash per Share$-0.68
FCF per Share$-0.38

Profitability & Financial Performance

Profit margins, return metrics, and earnings analysis

Profit Margins

Profitability margins across income statement

Gross Margin86.51%
EBITDA Margin (ttm)-13.01%
EBIT Margin (ttm)-43.03%
Operating Margin (ttm)-17.32%
Pretax Margin (ttm)-20.63%
Profit Margin (ttm)-24.88%
FCF Margin (ttm)-17.71%

Return on Investment Metrics

ROE, ROA, ROIC, and capital efficiency ratios

Return on Equity (ttm)-47.26%
Return on Assets (ttm)-21.27%
Return on Invested Capital (ttm)-40.23%
Return on Capital Employed (ttm)-68.66%

Income Statement (TTM)

Trailing twelve months revenue and earnings

Revenue59.57M
Gross Profit51.54M
Operating Income-10.32M
Pretax Income-12.29M
Net Income-14.82M
EBITDA-7.75M
EBIT-25.64M
Diluted EPS$-0.70

Cash Flow (TTM)

Operating cash flow and free cash flow metrics

Operating Cash Flow-7.66M
Capital Expenditures2.90M
Free Cash Flow-10.55M

Growth Rates (YoY)

Year-over-year growth metrics

Revenue Growth-39.15%

Financial Health & Dividends

Balance sheet analysis, debt ratios, and dividend metrics

Assets & Cash

Total assets and cash positions

Total Assets (mrq)69.70M
Cash & Securities (mrq)178.32K
Net Cash (mrq)-18.98M
Net Cash per Share$-0.68

Debt & Liabilities

Liabilities, debt, equity, and working capital

Total Debt (mrq)19.16M
Working Capital (mrq)22.61M
Total Equity (mrq)31.37M
Book Value per Share$1.13

Liquidity & Leverage

Liquidity, leverage, and debt coverage ratios

Current Ratio (mrq)1.70
Quick Ratio (mrq)1.66
Debt/Equity (mrq)0.61
Debt/EBITDA (ttm)1.88

Dividend History & Payout Analysis

Dividend yield, payout ratios, and growth metrics

Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%

Yield Metrics

Earnings, FCF, buyback, and shareholder yields

Earnings Yield-52.29%
FCF Yield-37.23%
Buyback Yield0.00%
Total Shareholder Yield0.00%

Financial Health Scores

Risk assessment and quality metrics

Altman Z-Score0.49
Piotroski F-Score1/9

Fair Value & Intrinsic Value

Lynch fair value, Graham number, and valuation models

Graham Number$2.39
Graham Upside/Downside133.87%

Frequently Asked Questions About Baird Medical Investment Holdings Statistics

What are the key financial metrics for BDMD?

Baird Medical Investment Holdings Limited (BDMD) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.

What is BDMD's valuation analysis?

The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Baird Medical Investment Holdings is overvalued or undervalued.

How do I read BDMD's profitability ratios?

Baird Medical Investment Holdings's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.

What do BDMD's debt ratios indicate?

The financial health section shows Baird Medical Investment Holdings's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.

What is BDMD's dividend analysis?

The dividend section covers Baird Medical Investment Holdings's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.